Cognitive and metabolic outcomes of vildagliptin addition to the therapy in patients with type 2 diabetes mellitus: 26 week follow-up study-Reference-Cited by-同舟云学术

Cognitive and metabolic outcomes of vildagliptin addition to the therapy in patients with type 2 diabetes mellitus: 26 week follow-up study

Published:2020-05 Issue: Volume:88 Page:104013
ISSN:0167-4943
Container-title:Archives of Gerontology and Geriatrics
language:en
Short-container-title:Archives of Gerontology and Geriatrics

Author:

Ates Bulut Esra^ORCID,Sahin Alak Zehra Yagmur^ORCID,Dokuzlar Ozge^ORCID,Kocyigit Suleyman Emre,Soysal Pinar^ORCID,Smith Lee,Isik Ahmet Turan

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Gerontology,Ageing,Health(social science)

Reference37 articles.

1. Standards of medical care in Diabetes-2019;2. Classification and Diagnosis of Diabetes Standards of Medical Care in Diabetes-2019;Diabetes Care,2019

2. Psychiatric disorders presenting in the elderly with type 2 diabetes mellitus;Alagiakrishnan;The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry,2012

3. Diagnostic and statistical manual of mental disorders;American Psychiatric Association,2013

4. DPP-4 inhibitors: A promising therapeutic approach against Alzheimer’s disease;Angelopoulou;Annals of Translational Medicine,2018

5. Diabetes in south and Central America: An update;Aschner;Diabetes Research and Clinical Practice,2014

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Contribution of Type 2 Diabetes to Parkinson’s Disease Aetiology;International Journal of Molecular Sciences;2024-04-15

2. Effects of DPP4 Inhibitors as Neuroprotective Drug on Cognitive Impairment in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis and Systematic Review;International Journal of Endocrinology;2024-02-13

3. Neuroprotective effects of dipeptidyl peptidase 4 inhibitor on Alzheimer’s disease: a narrative review;Frontiers in Pharmacology;2024-02-09

4. Glucose handling by the brain and its implication in metabolic syndrome;Metabolic Syndrome;2024

5. Dipeptidyl peptidase-4 inhibitors alleviate cognitive dysfunction in type 2 diabetes mellitus;Lipids in Health and Disease;2023-12-11